Cardiac Sarcoidosis;Kardiale Sarkoidose

Pneumologie

Volumn 57, Issue 12, 2003, Pages 752-760

  Schulte, W ^a   Costabel, U ^a   Kirsten, D ^b  

^a RUHRLANDKLINIK   (Germany)

^b KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTISONE;

ANGIOCARDIOGRAPHY; ARTIFICIAL HEART PACEMAKER; CARDIOMYOPATHY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART DILATATION; HEART DISEASE; HEART FUNCTION; HUMAN; IMAGING; MYOCARDIAL DISEASE; NUCLEAR MAGNETIC RESONANCE; PALLIATIVE THERAPY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SARCOIDOSIS; SCINTIGRAPHY;

ADRENAL CORTEX HORMONES; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; HUMANS; PREVALENCE; SARCOIDOSIS;

EID: 0346501790     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-812420     Document Type: Review

References (139)

1. Bernstein M, Konzelman FW, Sidlick DM. Boeck's sarcoid: report of a case with visceral involvement. Arch Intern Med 1929; 4: 721-734
2. Schaumann J. Etude anatomo-pathologique et histologique sur les localisationes viscerates de la lymphogranulomatose benigne. Bull Soc franc Dermat Syph 1933; 40: 1167-1171
3. Gentzen G. Über Riesenzellgranulome bei zwei Fällen von Endokardfibrose. Beiträge zur pathologischen Anatomie 1937; 98: 375
4. Gozo EG, Cosnow I, Cohen HC et al. The heart in sarcoidosis. Chest 1971; 60: 379-388
5. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993; 103: 253-258
6. Fleming H. Cardiac Sarcoidosis. In: James D ed. Sarcoidosis and other granulomatous disorders. New York: Marcel Dekker, 1994: 323-334
7. Shammas RL, Movahed A. Sarcoidosis of the heart. Clin Cardiol 1993; 16: 462-472
8. Kirsten D, Schaedel H. Herzbeteiligung bei Lungensarkoidose. Z Erkrank Atm Org 1984; 162: 99-107
9. Kirsten D, Schaedel H, Kessler G. Retrospektive Auswertung des Sarkoidosekrankengutes der Jahrgänge 1970-1979 der Zentralklinik für Herz- und Lungenkrankheiten in Bad Berka zur Auffindung möglicher Herzbeteiligung. Z Erkrank Atm Org 1984; 162: 108-117
10. Kirsten D. Sarkoidose in Deutschland. Pneumologie 1995; 49: 378-382
11. Kirsten D. Herzsarkoidose. Pneumologie 1994; 48: 737-743
12. Sharma OP. Diagnosis of cardiac sarcoidosis: an imperfect science, a hesitant art. Chest 2003; 123: 18-19
13. Flemming HA. Sarcoid heart disease. Br Heart J 1974; 36: 54-68
14. Johns CJ, Michele TM. The clinical management of sarcoidosis: a 50 year experience at the John Hopkins Hospital. Medicine 1999; 78: 65-111
15. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336: 1224-1234
16. Scadding JG. Sarcoidosis. London: Eyre and Spottiswoode, 1967: 291
17. American Thoracic Society. Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160: 736-755
18. Lynch JP, Sharma OP, Baughman RP. Extrapulmonary sarcoidosis. Semin Respir Infect 1998; 13: 229-254
19. Duke C, Rosenthal E. Sudden death caused by cardiac sarcoidosis in childhood. J Cardiovasc Electrophysiol 2002; 13: 939-942
20. Yigla M, Badarna-Abu-Ria N, Tov N et al. Sarcoidosis in northern Israel: clinical characteristics of 120 patients. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 220-226
21. Schaedel H, Kisten D, Schmidt H et al. Sarcoid heart disease results of follow up investigations. Eur Heart J 1991; 12: 26-27
22. Uemura A, Morimoto S. Cardiac sarcoidosis. Nippon Rinsho 2002; 60: 1794-1800
23. Arunabh S, Verma N, Brady TM. Massive pericardial effusion in sarcoidosis. Am Fam Physician 1998; 58: 660-662
24. Kinney EL, Jackson GL, Reeves WC et al. Thallium scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction : an analysis of 44 patients. Am J Med 1980; 68: 497-503
25. Tellier P, Paycha F, Antony I et al. Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med 1988; 85: 189-193
26. Fahy GJ, Marwick T, McCreery CJ et al. Doppler echocardiographic detection of the left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 1996; 109: 62-66
27. Burstow DJ, Tajik AJ, Bailey KR et al. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol 1989; 63: 478-482
28. Buckley BH, Rouleau JR, Whitaker JQ et al. The use of thallium for myocardial perfusion imaging in sarcoid heart disease. Chest 1977; 72: 27-32
29. Roberts WC, McAllister Jr HA, Ferrans VJ. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 2). Am J Med 1977; 63: 86-108
30. Silverman KJ, Hutchins GM, Buckley BH. Cardiac Sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-1211
31. Matsui Y, Iwai K, Tachibana T et al. Clinicopathological study on fatal myocardial sarcoidosis. Ann NY Acad Sci 1976; 278: 455-469
32. Longscope WT, Freiman DG. A study of sarcoidosis: based on a combined investigation on 160 cases, including 30 autopsies from John Hopkins Hospital and Massachusetts General Hospital. Medicine 1952; 3: 1-152
33. Perry A, Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995; 119: 167-172
34. Iwai K, Skiguchi M, Hosoda Y et al. Racial differences in cardiac sarcoidosis noted at autopsy. Sarcoidosis 1994; 11: 248-251
35. Gideon NM, Mannino DM. sarcoidosis mortality in the United States 1979-1991: an analysis of multiple cause mortality data. Am J Med 1996; 100: 423-427
36. Virmani R, Bures JC, Roberts WC. Cardiac sarcoidosis: a major cause of sudden death in young individuals. Chest 1980; 77: 423-428
37. Fleming HA. Sarcoid heart disease. Br Med J 1973; 1: 174-175
38. Sekiguchi M, Numao Y, Imai M et al. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. concepts through a study employing endomyocardial biopsy. 1: Sarcoidosis. Jpn Circ J 1980; 44: 249-263
39. Sekiguchi M, Yazaki Y, Isobe M et al. Cardiac sarcoidosis: diagnostic, prognostic and therapeutic considerations. Cardiovasc Drugs Ther 1996; 10: 495-510
40. Tachibana T, Ohmori F, Ueda E. Clinical study on cardiac sarcoidosis. Ann NY Acad Sci 1986; 465: 530-542
41. Stewart RE, Graham DM, Godfrey GW et al. Rapidly progressive heart failure resulting from cardiac sarcoidosis. Am Heart J 1988; 115: 1324-1326
42. Yazaki Y, Isobe M, Hiroe M et al. Prognostic determinants of long term survival in Japanese patients with cardiac sarcoidosis treated with prednisolone. Am J Cardiol 2001; 88: 1006-1010
43. Israel RH, Poe RH. Massive pericardial effusion in sarcoidosis. Respiration 1994; 61: 176-180
44. Garret J, O'Neill H, Blake S. Constrictive pericarditis associated with sarcoidosis. Am Heart J 1984; 107: 394-397
45. Yazaki Y, Hongo M, Hiroyochi Y et al. Cardiac sarcoidosis in Japan: treatment and prognosis. In: Sekiguchi M, Richardson PJ. Prognosis and treatment of cardiomyopathy and myocarditis. Tokyo: Univ of Tokyo Press, 1994: 351-353
46. Zoneraich S, Gupta MP, Metha J et al. Myocardial sarcoidosis presenting as acute mitral insufficiency. Chest 1974; 66: 452-454
47. Numao Y, Sekiguchi M, Fruie T et al. A study of cardiac involvement in 963 cases of sarcoidosis by ECG and endomyocardial biopsy. Ann NY Acad Sci 1976; 76: 607-614
48. Gibbons WJ, Levy RD, Nava S et al. Subclinical cardiac dysfunction in sarcoidosis. Chest 1991; 100: 44-50
49. Suzuki T, Kanda T, Kubota S et al. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 1994; 106: 1021-1024
50. Thunell M, Bjerle P, Karp K et al. Exercise test in patients with sarcoidosis: the importance of repolarization disturbances. Acta Med Scand 1988; 223: 69-73
51. Larsen F, Pehrsson SK, Hammar N et al. ECG-abnormalities in Japanese and Swedish patients with sarcoidosis. A Comparison. Sarcoidosis Vasc diffuse Lung Dis 2001; 18: 284-288
52. Delobbe A, Perault H, Maitre J et al. Impaired exercise response in sarcoid patients with normal pulmonary function. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 148-153
53. Kinney E, Murthy R, Ascunce G et al. Pericardial effusions in sarcoidosis. Chest 1979; 76: 476-478
54. Angomachalelis N, Hourzamanis A, Salem N et al. Pericardial effusion concomitant with specific heart musle disease in systemic sarcoidosis. Postgrad Med J 1994; 70: S8-S12
55. Shiff AD, Blatt CJ, Colp C. Recurrent pericardial effusion secondary to sarcoidosis of the pericardium.
56. Lewin RF, Mor R, Spitzer S et al. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 1985; 110: 116-122
57. Gregor P, Widimsky P, Sladkova T et al. Echocardiography in sarcoidosis. Jpn Heart J 1984; 25: 499-508
58. Friart A, Philippart C, Bruart J. Echocardiography in systemic sarcoidosis. Lancet 1987; 1: 513
59. Moiseyev SV, Kornev BM, Shatkovsky NP et al. Noninvasive diagnosis of cardiac sarcoidosis. Lancet 1987; 2: 739-740
60. Winter SL, Cohen M, Grennberg S et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and implantable anti-tachycardia device. J Am Coll Cardial 1997; 18: 937-943
61. Le Guludec D, Menad F, Faraggi M et al. Myocardial sarcoidosis: clinical value of technetium-99m-sestamibi tomo-scintigraphy. Chest 1994; 106: 1675-1682
62. Tellier P, Valeyre D, Nitenberg A et al. Cardiac sarcoidosis: reversion of myocardial perfusion abnormalities by dipyridamole. Eur J Nucl Med 1985; 11: 201-204
63. Yamamoto N, Gotoh K, Yagi Y et al. Thallium-201-myocardial SPECT findings at rest in sarcoidosis. Ann Nucl Med 1993; 7: 97-103
64. Valeyre D, Marsac J, Gambini G et al. Assessment of sarcoid heart disease: a study of 37 patients with thoracic sarcoidosis. In: Chretien J, Marsac J, Saltiel JC (eds.). Sarcoidosis and other granulomatous diseases. Oxford: Pergamon, 1983: 296-300
65. Haywood LJ, Sharma OP, Siegel ME et al. Detection of myocardial sarcoidosis by thallium201 imaging. J Natl Med Assoc 1982; 74: 959-964
66. Fields CL, Ossorio MA, Roy TM et al. Thallium-201 scintigraphy in the diagnosis and management of myocardial sarcoidosis. South Med J 1990; 83: 339-342
67. Okayama K, Kurata C, Tawarahara K et al. Diagnostic and prognostic Value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995; 107: 330-334
68. Mana J. Nuclear imaging: 67 Gallium, 201 thallium, 18F-labelled fluoro-2-deoxy-D-glucose positron emission tomography. Clin Chest Med 1997; 18: 799-811
69. Nitenberg A, Foult JM, Blanchet F et al. Multifactorial determinants of reduced coronary flow reserve in after dipyridamole in dilated cardiomyopathy. Am J Cardiol 1985; 55: 748-754
70. Shimada T, Shimada K, Sakane T et al. Diagnosis of cardiac sarcoidosis and the evaluation of the effect of steroid therapy by Gadolinium -DTPA-enhanced magnetic resonance imaging. Am J Med 2001; 110: 520-527
71. Skold CM, Larsen FF, Rasmussen E et al. Determination of cardiac involvement in sarcoidosis by magnetic resonance imaging and Doppler echocardiography. J Intern Med 2002; 252 (5): 465-471
72. Vignaux O, Dhote R, Duboc D et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow up study. Chest 2002; 122: 1895-1901
73. Tajima T, Naito T, Dohi Y et al. Ga-67 and TI-201 imaging in sarcoidosis involving myocardium. Clin Nucl Med 1981; 6: 120-121
74. Nagatomo Y, Imamura T, Koiwaya Y et al. Thallium-201 and gallium-67 myocardial scintigraphy for the evaluation of sarcoid involvement. Clin Nucl Med 1987; 12: 335-336
75. Hirose Y, Ishida Y, Hayashida K et al. Myocardial involvement in patients with sarcoidosis: an analysis of 75 patients. Clin Nucl Med 1994; 19: 522-526
76. Kurata C, Sakata K, Taguchi T et al. SPECT imaging with TI-201 and Ga-67 in myocardial sarcoidosis. Clin Nucl Med 1990; 15: 408-411
77. Taki J, Nakajima K, Bunko H et al. Cardiac sarcoidosis demonstrated by TI-201 and Ga-67 SPECT imaging. Clin Nucl Med 1990; 15: 636-639
78. Tawarahara K, Kurata C, Okayama K et al. Thallium-201 and gallium-67 single photon emission computed tomographic imaging in cardiac sarcoidosis. Am Heart J 1992; 124: 1383-1384
79. Riedy K, Fisher MR, Belic N et al. MR imaging of myocardial sarcoidosis. Am J Roentgenol 1988; 151: 915-916
80. O'Connell JB, Henkin RE, Robinson JA et al. Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. Circulation 1984; 70: 58-62
81. Forman MB, Sandler MP, Sacks GA et al. Radionuclide imaging in myocardial sarcoidosis : demonstration of myocardial uptake of technetium 99 m pyrophosphate and gallium. Chest 1983; 83: 578-580
82. Angomachalellis N. Radionuclide imaging of specific heart musle disease in systemic sarcoidosis. Sarcoidosis 1992; 9: 245-253
83. Eguchi M, Tsuchihashi K, Hotta D et al. Technetium 99 m sestamibi/tetrofosmin myocardial perfusion scannino in cardiac and noncardiac sarcoidosis. Cardiology 2000; 94: 193-199
84. Nishijima K, Miyahara Y, Furukawa K et al. Simultaneous assessment of right ventricular function and hypertrophy by Tc-99 m MIBI. Clin Nucl Med 1999; 24: 151-155
85. Doherty MJ, Kumar SK, Nicholson AA et al. Cardiac sarcoidosis: the value of magnetic resonance imaging in diagnosis and assessment of response to treatment. Respir Med 1998; 92: 697-699
86. Eliasch H, Juhlin-Dannfelt A, Sjogren I et al. Magnetic resonance imaging as an aid to the diagnosis and treatment evaluation of suspected myocardial sarcoidosis in a fighter pilot. Aviat Space Environ Med 1995; 66: 1010-1013
87. Matsuki M, Matsuo M. MR findings of myocardial sarcoidosis. Clin Radiol 2000; 55: 323-325
88. Dupis JM, Victor J, Furber A et al. Magnetic resonance imaging in cardiac sarcoidosis: a case report. Arch Mal Coeur 1994; 87: 105-110
89. Chandra M, Silverman ME, Oshinski J et al. Diagnosis of cardiac sarcoidosis aided by MRI. Chest 1996; 110: 562-565
90. Bajaj AK, Kopelman HA, Echt DS. Cardiac sarcoidosis with sudden death: treatment with the automatic implantable cardioverter defibrillator. Am Heart J 1988; 116: 557-560
91. Danias PG. Gadolinium-enhanced cardiac magnetic resonance imaging: expanding the spectrum of clinical applications. Am J Med 2001; 110: 591-592
92. Rieker O, Mohrs O, Oberholzer K et al. Cardiac MRI in suspected Myocarditis. Rofo Fortschr Geb Roentgenstr Neuen Bildgeb Verfahr 2002; 174: 1530-1536
93. Vignaux O, Dhote R, Duboc D et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr 2002; 26: 762-767
94. Mahrholdt H, Wagner A, Geissler A et al. Infarkt- und Vitalitätsdiagnostik mittels Kontrast-verstärkter Magnetresonanztomografie. Dtsch Med Wochenschr 2002; 127: 1264-1271
95. Takedo N, Yokoyama I, Hiroe Y et al. Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis. Circulation 2002; 105: 1144-1145
96. Okumura W, Iwasaki T, Ueda T et al. Usefulness of 18F-FDG PET for diagnosis of cardiac sarcoidosis. Kaku Igaku 1999; 36: 341-348
97. Ishikawa T, Kondoh H, Nakagawa S et al. Steroid therapy in cardiac sarcoidosis: increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone. Chest 1984; 85: 445-447
98. Lorell B, Alderman EL, Mason JW. Cardiac sarcoidosis: diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol 1978; 42: 143-146
99. Uemura A, Morimoto S, Hiramitsu S et al. Histologic diagnostic rate of cardiac sarcoidosis. Evaluation of endomyocardial biopsies. Am Heart J 1999; 138: 299-302
100. Ratner SJ, Fenoglio JJ, Ursel P. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest 1986; 90: 528-533
101. Yazaki Y, Isobe M, Hiramitsu S et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 1998; 82: 537-540
102. Takada K, Ina Y, Yamamoto M et al. Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan: clinical evaluation of corticosteroid therapy. Sarcoidosis 1994; 11: 113-117
103. Baughman RP, Sharma OP, Lynch JP III. Sarcoidosis: is therapy effective? Semin Respir Infect 1998; 13: 255-273
104. Hiyama K. Corticosteroid therapy for sarcoidosis. Nippon Rinsho 2002; 60: 1827-1833
105. Konishi M, Yoneda K, Takahashi K et al. Non-steroid therapy for sarcoidosis. Nippon Rinsho 2002; 60: 1834-1838
106. Baughman RP, Ohmichi M, Lower EE. Combination therapy for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 133-137
107. Lynch JP, McCune WJ. Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am J Respir Crit Care Med 1997; 155: 395-420
108. Zic JA, Horowitz DH, Arzubiaga C et al. Treatment of cutaneous sarcoidosis with chloroquine: review of the literature. Arch Dermatol 1991; 127: 1034-1040
109. Baltzan M, Mehta S, Kirkham TH et al. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 1999; 160: 192-197
110. Adams JS, Diz MM, Sharma OP. Effective reduction in the serum 1,25-dihydroxyvitamine D and Calcium concentration in sarcoidosis-associated hypercalcemia with short course chloroquine therapy. Ann Intern Med 1989; 111: 437-438
111. Sharma OP. Neurosarcoidosis: a personal perspective based on the study of 38 patients. Chest 1997; 112: 220-228
112. Kaye O, Pallazo E, Grossin M et al. Low dose methotrexate: an effective corticosteroid sparing-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumatol 1995; 34: 642-644
113. Webster GF, Razsi LK, Sanchez M et al. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol 1991; 24: 451-454
114. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999; 54: 742-746
115. Müller-Quernheim J, Kienast K, Held M et al. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Resp J 1999; 14: 1117-1122
116. Agbogu BN, Stern BJ, Sewell C et al. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995; 52: 875-879
117. Lower EE, Broderick JP, Brott TG et al. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157: 1864-1868
118. Demeter SL. Myocardial sarcoidosis unresponsive to steroids: treatment with cyclophosphamide. Chest 1988; 94: 202-203
119. Stern BJ, Schonfeld SA, Sewell C et al. The treatment of neurosarcoidosis with cyclosporine. Arch Neurol 1992; 49: 1065-1072
120. Martinet Y, Pinkston P, Saltini C et al. Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis on active pulmonary sarcoidosis. Am Rev Respir Dis 1988; 138: 1242-1248
121. Wyser CP, Schalkwyk EM van, Alheit B et al. Treatment of progressive pulmonary sarcoidosis with cyclosporin A: a randomized controlled trial. Am J Respir Crit Care Med 1997; 156: 1371-1376
122. Carlesimo M, Giustini S, Rossi A et al. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J Am Acad Dermatol 1995; 32: 866-869
123. Baughman RP, Judson MA, Teirstein AS et al. Thalidomide for chronic sarcoidosis. Chest 2002; 122: 227-232
124. Zabel P, Entzian P, Dalhoff K et al. Pentoxifylline in the treatment of sarcoidosis. Am J Respir Crit Care Med 1997; 155: 1665-1669
125. Baughman RP. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 70-74
126. Yee AM, Pochapin MB. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 2001; 135: 27-31
127. Mezaki T, Chinushi M, Washizuka T et al. Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis: requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis. Intern Med 2001; 40: 731-735
128. Huang PL, Brooks R, Carpenter C et al. Anti-arrhythmic therapy guided by programmed electrical stimulation in cardiac sarcoidosis with ventricular tachycardia. Am Heart J 1991; 121: 599-601
129. Kowey PR, Waxman HL, Greenspon A et al. Value of electro physiologic testing in patients with previous myocardial infarction and non-sustained ventricular tachycardia. Philadelphia Arrhythmia Group. Am J Cardiol 1990; 65: 594-598
130. Poll DS, Marchlinski FE, Buxton AE et al. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986; 58: 992-997
131. Hsia HH, Marchlinski FE. Electrophysiology studies in patients with dilated cardiomyopathy. Card Electrophysiol Rev 2002; 6: 472-481
132. Huikuri HV, Castellanos A, Myersburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001; 345: 1473-1482
133. Paz HL, McCormick DJ, Kutalek SP et al. The automated implantable cardiac defibrillator: prophylaxis in cardiac sarcoidosis. Chest 1994; 106: 1603-1607
134. Oni AA, Hershberger RE, Norman DJ et al. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 1992; 11: 367-369
135. Martinez FJ, Orens JB, Deeb M et al. Recurrence of sarcoidosis following bilateral allogenic lung transplantation. Chest 1994; 106: 1597-1599
136. Valantine HA, Tazelaar HD, Macoviak J et al. Cardiac sarcoidosis: response to steroids and transplantation. J Heart Transplant 1987; 6: 244-250
137. Shorr AF, Davies DB, Nathan SD. Outcomes for patients with sarcoidosis awaiting lung transplantation. Chest 2002; 122: 233-238
138. Meyer A, Schafer H, Doring V et al. Heart transplantation in myocardial sarcoidosis. Studies on the explanted heart.Dtsch Med Wochenschr 1999; 124: 1131-1134
139. Angomachalelis N, Hourzamanis A, Vamvalis C et al. Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic sarcoidosis. Postgrad Med J 1992; 68: 52-56